SE0402520D0 - Method - Google Patents
MethodInfo
- Publication number
- SE0402520D0 SE0402520D0 SE0402520A SE0402520A SE0402520D0 SE 0402520 D0 SE0402520 D0 SE 0402520D0 SE 0402520 A SE0402520 A SE 0402520A SE 0402520 A SE0402520 A SE 0402520A SE 0402520 D0 SE0402520 D0 SE 0402520D0
- Authority
- SE
- Sweden
- Prior art keywords
- par3
- asthma
- csf
- tnf
- antagonists
- Prior art date
Links
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to the use of antagonists of a protease- activated receptor, PAR3, for the treatment of asthma. The presence of pro- inflammatory cytokines, such as TNF- alpha or ILl-beta, thrombin interacts with PAR3 resulting in the induction of GM-CSF to a level that is found in asthma.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0402520A SE0402520D0 (en) | 2004-10-18 | 2004-10-18 | Method |
PCT/SE2005/001547 WO2006054931A1 (en) | 2004-10-18 | 2005-10-17 | The use and identification of antagonists of protease-activated receptor 3 (par3) in the treatment of asthma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0402520A SE0402520D0 (en) | 2004-10-18 | 2004-10-18 | Method |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0402520D0 true SE0402520D0 (en) | 2004-10-18 |
Family
ID=33448650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0402520A SE0402520D0 (en) | 2004-10-18 | 2004-10-18 | Method |
Country Status (2)
Country | Link |
---|---|
SE (1) | SE0402520D0 (en) |
WO (1) | WO2006054931A1 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004083864A1 (en) * | 2003-03-17 | 2004-09-30 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 3 (par3) |
-
2004
- 2004-10-18 SE SE0402520A patent/SE0402520D0/en unknown
-
2005
- 2005-10-17 WO PCT/SE2005/001547 patent/WO2006054931A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2006054931A1 (en) | 2006-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL301145I2 (en) | Tirbanibulin | |
NL301089I2 (en) | imlifidase | |
NO20054371L (en) | Somatostatin-dopamine chimeric analogs | |
AU2003272285A8 (en) | Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands | |
EA201170521A1 (en) | NEW CONNECTIONS | |
DE602005020799D1 (en) | HUMANIZED ANTI-CMET ANTAGONISTS | |
TW200801006A (en) | Fused bicyclic mTOR inhibitors | |
DK3530673T3 (en) | Humanized anti-beta7 antagonists and uses thereof | |
MX2009008617A (en) | Use of il-23 antagonists for treatment of infection. | |
MX2009008104A (en) | Hepcidin, hepcidin antagonists and methods of use. | |
MXPA06014510A (en) | Compositions and methods for treating inflammatory disorders. | |
ATE497492T1 (en) | CLEANING MONTELUKAST | |
TW200700064A (en) | Novel compounds | |
ATE484501T1 (en) | BENZIMIDAZOLES USABLE AS PROTEIN KINASE INHIBITORS | |
GEP20115201B (en) | Cinnamoyl-piperazine derivatives and their use as par- i antagonists | |
GB0426313D0 (en) | Therapeutic agents | |
ATE475651T1 (en) | ARYL-SUBSTITUTED HETEROCYCLES AND THEIR USE | |
NO20075662L (en) | Roflumilast for the treatment of pulmonary hypertension | |
ATE410235T1 (en) | TREATMENT OF BALLAST WATER | |
ATE455789T1 (en) | SUBSTITUTED NONADEPSIPEPTIDES | |
ATE410443T1 (en) | HETEROCYCLYL-SUBSTITUTED NONADEPSIPEPTIDES | |
EA201001872A1 (en) | NEW WAYS TO OBTAIN CYCLOPROPYLAMIDE DERIVATIVES | |
CY1109803T1 (en) | PHARMACEUTICAL COMPOSITES BASED ON NK2 COMPONENTS FOR PEDIATRIC USE | |
SE0402520D0 (en) | Method | |
DE602004019541D1 (en) | CYCLOALKYLÄBÜ CONDENSED INDOLE |